ACS Biomarker B.V. i.o., BG Medicine deal

BG Medicine received exclusive, worldwide rights to develop and commercialize molecular diagnostics for congestive heart failure (CHF) based on ACS Biomarker's galectin-3 and thromboplastin-2 blood p...